RAPT Therapeutics Inc (NASDAQ: RAPT) is -23.42% lower on its value in year-to-date trading and has touched a low of $0.79 and a high of $27.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RAPT stock was last observed hovering at around $1.32 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $1.21, the stock is -9.98% and -17.42% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.47 million and changing -8.33% at the moment leaves the stock -63.09% off its SMA200. RAPT registered -95.03% loss for a year compared to 6-month loss of -64.72%. The firm has a 50-day simple moving average (SMA 50) of $1.48096 and a 200-day simple moving average (SMA200) of $3.314065.
The stock witnessed a 11.01% gain in the last 1 month and extending the period to 3 months gives it a -27.54%, and is -27.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.02% over the week and 14.31% over the month.
RAPT Therapeutics Inc (RAPT) has around 131 employees, a market worth around $42.30M and $0.00M in sales. Distance from 52-week low is 53.31% and -95.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.57%).
The EPS is expected to grow by 30.11% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
RAPT Therapeutics Inc (RAPT) Top Institutional Holders
142.0 institutions hold shares in RAPT Therapeutics Inc (RAPT), with institutional investors hold 85.59% of the company’s shares. The shares outstanding are 34.96M, and float is at 34.96M with Short Float at 10.18%. Institutions hold 84.02% of the Float.
The top institutional shareholder in the company is FMR LLC with over 5.24 million shares valued at $15.97 million. The investor’s holdings represent 13.5546% of the RAPT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.11 million shares valued at $9.48 million to account for 8.0472 of the shares outstanding. The other top investors are COLUMN GROUP LLC which holds 2.68 million shares representing 6.9401% and valued at over $8.18 million, while BLACKROCK INC. holds 6.3167 of the shares totaling 2.44 million with a market value of $7.44 million.
RAPT Therapeutics Inc (RAPT) Insider Activity
#####
